Market Intelligence

Is Lamar Lamr Stock Leading The Market Price At 133.67 Up 0.60 20260410 Crai Stock Analysis Cra International Inc. Up 0.67 Percent To Trade At 165 Usd 20260403 1 Is Radiopharm Radx Stock Priced Correctly Price At 4.50 Up 3.45 20260408 What Caused Axt Axti Stock To Drop Recently Price At 60.50 Up 13.76 20260409 Daily Market Overview S And P 500 Nasdaq Edge Up Dow Posts Small Dip 20260408 1 AARD Aardvark Q4 earnings beat modest estimates but stock declines on zero revenue concerns TAYD Taylor Devices Inc posts narrow Q1 2026 EPS beat and 38 percent yearly revenue gain shares dip 104 percent Sureste ASR Stock Volume Spike Trend Weakens 20260416 ASP Isotopes ASPI Stock Sentiment Overview Rallies Strongly 20260418 Consolidated Edison Inc ED PreEarnings Analysis and Outlook Ahead of Fiscal 2026 First Quarter Results PHR Phreesia posts 145 Q1 2026 revenue growth but misses EPS estimates sharply stock dips 043 today Beta Bionics BBNX Peer Comparison Beta Bionics posts 316 EPS beat on strong topline results ADBE Adobe Q1 2026 results top EPS estimates 105 percent year over year revenue growth lifts shares 163 percent TYRA Tyra Biosciences falls 335 after widerthanexpected Q4 2025 earnings loss dents investor confidence LITE Lumentum Holdings tops Q1 2026 EPS estimates by 174 percent shares climb 513 percent on positive investor sentiment What initial margin Playtika Holding PLTK Near Highs 20260429 Phillips 66 PSX Western Gateway Pipeline Advancement KMI Partnership Reinforce LongTerm Cash Flow Visibility Is GEE Group JOB stock expensive compared to peers Q4 2025 EPS Misses Views DE Deere delivers double digit Q1 2026 EPS beat shares rise over 5 percent on upbeat investor reaction Federal Reserve Governor Miran Resigns Endorses Kevin Warsh as Next Chair Jim Cramer Warns of Valuation Risk in RedHot AI IPO Cerebras Innovex International INVX Stock Analysis Climbs 098 Eyes on 2927 20260515 Horizon HQ Slips 300 Testing 1124 Support 20260515 DTE Energy DTK Drops 102 Key Support at 2316 20260515 Tata Motors Employees Poised for 168 Crore Windfall Under New Performance Share Plan Tortoise TYG Falls 060 Watching 4455 Support 20260515 ASE Tech ASX Crushes Q1 2026 Estimates EPS 308 Tops Views MAXN Q4 2024 Earnings Strong EPS Beat Driven by Cost Discipline Amid Revenue Uncertainty BioVie BIVI Delivers Q1 2026 Beat EPS 070 vs 074 Expected Potential Political Implications of Tamil Thaai Vaazhthu Sequencing Dispute in Tamil Nadu Skeena SKE Q4 2025 Results Miss Estimates EPS 013 vs 011 China Urges APEC Cooperation as Commerce Minister Skipped Opening Over Urgent Official Business Microsoft and Anthropic in Talks for Custom AI Chip Deal Following 5 Billion Investment Borosil Glass Works Shares Surge Over 200 in a Year on Strong Revenue Growth New York Fed Study Reveals Surging Gas Prices Disproportionately Impact LowerIncome Households SpaceX OpenAI and Anthropic IPOs Could Test the Limits of the AI Boom SOJE Q1 2026 Earnings Southern Companys Junior Subordinated Notes Benefit from Solid Utility Earnings Beat MDXG Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges Embecta Corp EMBC Q1 2026 Earnings EPS Misses Estimates as Revenue Remains Undisclosed PSNY Q4 2024 Earnings WiderthanExpected Loss Amidst Operational Challenges Okta Inc OKTA Q1 2026 Earnings EPS Beat Drives Modest Stock Gain Amid Revenue Ambiguity Fortune Brands Innovations FBIN Gains 175 Testing Resistance Near 40 Australian Oilseeds Holdings Warrants COOTW Surge 105 but Remain Near AllTime Lows Blackstone Secured Lending Fund BXSL Edges Lower as Support Levels Come Into Focus Sphere Entertainment Co SPHR Holds Near Key Support After Modest Decline Walmart Eyes Price Cuts With Tariff Refunds as Consumer Stress Rises Airship AI Holdings Inc AISP Q3 2025 Earnings A Net Loss That Missed Estimates by a Wide Margin Hydrofarm Holdings HYFM Q3 2025 Earnings DeeperthanExpected Loss Despite Modest Stock Uptick Woodward WWD Q1 2026 Earnings Strong EPS Beat Bolstered by Operational Gains Yet Shares Edge Lower BLTE Q4 2025 Earnings WiderthanExpected Loss as PreRevenue Biotech Remains Focused on Clinical Development